New drug combo trial offers hope for Tough-to-Treat salivary gland cancers
NCT ID NCT04895735
Summary
This study is testing whether combining two existing drugs—pemetrexed (chemotherapy) and pembrolizumab (immunotherapy)—can help control advanced salivary gland cancer. It is for adults whose cancer has returned or spread and is not curable with surgery or radiation. The main goal is to see if this combination can shrink tumors or stop the cancer from growing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOID CYSTIC CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Mayo Clinic in Arizona
Scottsdale, Arizona, 85259, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.